Pulmonx Corp - COM (LUNG)

Historical Holders from Q4 2020 to Q3 2025

Symbol
LUNG on Nasdaq
Type / Class
Equity / COM
Shares outstanding
40,762,262
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
31,835,102
Holdings value
$51,571,421
% of all portfolios
0%
Number of holders
103
Number of buys
50
Number of sells
-55
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Pulmonx Corp - COM (LUNG)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PRIMECAP MANAGEMENT CO/CA/ 12.16% -10.4% $8,029,839 -$742,073 4,956,691 -8.5% PRIMECAP MANAGEMENT CO/CA/ 30 Sep 2025
MORGAN STANLEY 8.5% +12.5% $17,530,110 +$2,200,052 3,390,737 +14.4% Morgan Stanley 31 Mar 2025
BlackRock, Inc. 6.8% $13,933,140 2,694,998 BlackRock, Inc. 31 Mar 2025
FMR LLC 0.2% -1% $114,736 -$3,416,852 70,825 -96.8% FMR LLC 31 Oct 2025

Institutional Holders of Pulmonx Corp - COM (LUNG)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 31,835,102 $51,571,421 -$11,678,501 $1.62 103
2025 Q2 36,256,022 $93,898,311 -$4,596,833 $2.59 113
2025 Q1 36,156,132 $243,324,576 +$1,663,003 $6.73 114
2024 Q4 35,870,967 $243,565,337 +$1,640,704 $6.79 117
2024 Q3 35,563,337 $293,811,542 +$7,857,689 $8.29 112
2024 Q2 34,744,517 $220,280,080 -$2,027,570 $6.34 108
2024 Q1 34,672,382 $321,430,455 +$7,599,744 $9.27 117
2023 Q4 33,520,168 $427,381,569 +$18,995,295 $12.75 122
2023 Q3 33,253,122 $343,505,198 -$6,689,600 $10.33 113
2023 Q2 33,869,172 $443,992,925 -$9,642,079 $13.11 112
2023 Q1 34,707,575 $388,032,205 +$25,513,692 $11.18 101
2022 Q4 33,773,100 $284,706,913 -$83,075,336 $8.43 111
2022 Q3 34,912,391 $581,637,070 -$4,909,166 $16.66 100
2022 Q2 35,341,147 $520,187,047 -$7,902,826 $14.72 102
2022 Q1 34,711,340 $861,059,885 +$56,937,629 $24.81 105
2021 Q4 32,045,807 $1,027,712,027 +$25,949,573 $32.07 108
2021 Q3 31,600,475 $1,136,986,158 +$204,291,164 $35.98 118
2021 Q2 25,771,799 $1,136,970,052 +$216,275,676 $44.12 112
2021 Q1 20,788,776 $950,879,909 +$115,760,357 $45.74 107
2020 Q4 17,288,638 $1,179,671,046 +$1,018,686,046 $69.02 98